Skip survey header

COG/ASPHO Joint Sponsorship: Updates in Rare Tumors

Page One

This question requires a valid email address.
3. Objectives:
  1. Describe current staging and risk stratification standards for retinoblastoma, hepatoblastoma, and germ cell tumors
  2. Discuss results from recently completed clinical trials in children with retinoblastoma, hepatoblastoma, and germ cell tumors.
  3. Recognize the important role of international collaboration in developing clinical trials for pediatric rare tumors.
  4. Discuss the importance of interdisciplinary collaboration in the treatment of pediatric rare tumors.
*This question is required.Please rate your level of agreement with the following statement:
Presenters met stated learning objectives
4. Speaker Evaluation-Please rate your level of agreement for each speaker on the following: *This question is required.Presenter was effective
Space Cell 5-Agree Strongly4-Agree Moderately3-Neither Agree nor Disagree2-Disagree Moderately1-Disagree StronglyN/A
Murali Chintagumpala, MD
Lindsay Frazier, MD
Rebecka Meyers, MD
Carlos Rodriguez-Galindo, MD
5. Demonstrated expertise in content area *This question is required.
Space Cell 5-Agree Strongly4-Agree Moderately3-Neither Agree nor Disagree2-Disagree Moderately1-Disagree StronglyN/A
Murali Chintagumpala, MD
Lindsay Frazier, MD
Rebecka Meyers, MD
Carlos Rodriguez-Galindo, MD
6. Presentation was scientifically rigorous, balanced, and free of commercial bias *This question is required.
Space Cell 5-Agree Strongly4-Agree Moderately3-Neither Agree nor Disagree2-Disagree Moderately1-Disagree StronglyN/A
Murali Chintagumpala, MD
Lindsay Frazier, MD
Rebecka Meyers, MD
Carlos Rodriguez-Galindo, MD
7. Please identify how you will change your practice as a result of attending this activity (select all that apply). *This question is required.